Ocular immune privilege and retinal pigment epithelial cells
Y Du, B Yan - Journal of Leukocyte Biology, 2023 - academic.oup.com
The ocular tissue microenvironment is immune-privileged and uses multiple
immunosuppressive mechanisms to prevent the induction of inflammation. The retinal …
immunosuppressive mechanisms to prevent the induction of inflammation. The retinal …
Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non‐infectious uveitis
LB Ferreira, KA Williams, G Best… - Clinical & …, 2023 - Wiley Online Library
Characterised by intraocular inflammation, non‐infectious uveitis includes a large group of
autoimmune and autoinflammatory diseases that either involve the eye alone or have both …
autoimmune and autoinflammatory diseases that either involve the eye alone or have both …
Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells
M Llorián-Salvador, EM Byrne, M Szczepan… - Journal of …, 2022 - Springer
Background We previously reported higher plasma levels of complement fragments C3a
and C5a in neovascular Age-related Macular Degeneration (nAMD) patients with macular …
and C5a in neovascular Age-related Macular Degeneration (nAMD) patients with macular …
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy
Blood-retinal barrier (BRB) disruption is a common accompaniment of intermediate,
posterior and panuveitis causing leakage into the retina and macular oedema resulting in …
posterior and panuveitis causing leakage into the retina and macular oedema resulting in …
Wnt signaling in inner blood–retinal barrier maintenance
The retina is a light-sensing ocular tissue that sends information to the brain to enable
vision. The blood–retinal barrier (BRB) contributes to maintaining homeostasis in the retinal …
vision. The blood–retinal barrier (BRB) contributes to maintaining homeostasis in the retinal …
[HTML][HTML] Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
S Nashine, P Cohen, J Wan, MC Kenney - Aging (Albany NY), 2022 - ncbi.nlm.nih.gov
Inflammation plays a crucial role in the etiology and pathogenesis of AMD (Age-related
Macular Degeneration). Humanin G (HNG) is a Mitochondrial Derived Peptide (MDP) that is …
Macular Degeneration). Humanin G (HNG) is a Mitochondrial Derived Peptide (MDP) that is …
Network pharmacology mechanism of Scutellarin to inhibit RGC pyroptosis in diabetic retinopathy
N Li, XL Guo, M Xu, JL Chen, YF Wang, YG Xiao… - Scientific Reports, 2023 - nature.com
To investigate the effect of scutellarin (SCU) in diabetic retinopathy (DR) and explore the
associated molecular network mechanism. The animal model of DR was established from …
associated molecular network mechanism. The animal model of DR was established from …
Peripheral blood mononuclear cells from patients with type 1 diabetes and diabetic retinopathy produce higher levels of IL-17A, IL-10 and IL-6 and lower levels of IFN …
Inflammation is key to the pathogenesis of diabetic retinopathy (DR). This prospective study
investigated alterations in inflammatory cytokines in peripheral blood mononuclear cells …
investigated alterations in inflammatory cytokines in peripheral blood mononuclear cells …
The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern
WJ Sun, XD An, YH Zhang, XF Zhao, YT Sun… - Frontiers in …, 2023 - frontiersin.org
Diabetic retinopathy (DR) is a prevalent complication of diabetes, significantly impacting
patients' quality of life due to vision loss. No pharmacological therapies are currently …
patients' quality of life due to vision loss. No pharmacological therapies are currently …
Anti-IL17a halts the onset of diabetic retinopathy in type I and II diabetic mice
AY Zhou, BE Taylor, KG Barber, CA Lee… - International Journal of …, 2023 - mdpi.com
There are~ 463 million diabetics worldwide, and more than half have diabetic retinopathy.
Yet, treatments are still lacking for non-proliferative diabetic retinopathy. We and others …
Yet, treatments are still lacking for non-proliferative diabetic retinopathy. We and others …